UNSPSC 51391712: Clenbuterol
Commodity
Code facts
- Part of
-
-
51000000
-
51390000
- 51391700
-
51390000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51391712
| NIGP code |
|---|
| 26912 Autonomic Drugs |
Definition
This classification denotes a bronchodilator and beta-adrenergic agonist with the molecular formula C12H18Cl2N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XTZ6AXU7KN, chemically known as 4-amino-alpha-((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol but generally known as clenbuterol, which bears US NIH Compound Identifier 2783. European Medicines Agency schedules Clenbuterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06651MIG.
Read the full definition
The term CLENBUTEROL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, No. 10 1973, List 13). World Health Organization schedules clenbuterol in its Anatomical Therapeutic Chemical (ATC) Classification. CLENBUTEROL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clenbuterol under HS 29221980 and SITC 51461. As of Q4 2014, CLENBUTEROL remains the US FDA Preferred Term for this commodity.
Clenbuterol bears US NLM identifiers UMLS ID C0008932 and NCI Concept Code C65335. SMILES: CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O.
About UNSPSC 51391712
UNSPSC 51391712 Clenbuterol is a Commodity code with minimal recent state and local procurement activity aligned to its nominal scope. The single recent opportunity posted under this code—Seminole County, Florida's IFB 60459723LAS—solicits naloxone and drug deactivation systems for community health initiatives, not clenbuterol. The mismatch suggests either a coding error in the county's procurement classification or that the code's recent activity does not reflect its intended pharmaceutical or veterinary use case. When present, state and local procurement under this code appears to involve medical or emergency-response products tied to public health and opioid-response initiatives rather than the specific pharmaceutical agent the code nominally describes.
Seminole County represents the only recent issuing body on record. The county released the naloxone and drug deactivation systems IFB on June 30, 2026, with a response deadline of July 26, 2026, seeking 1,900 units of naloxone and 800 deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Bidders must include all shipping and delivery costs, comply with E-Verify and drug-free workplace requirements, carry standard commercial insurance, and accept a three-month probationary period with at-will termination rights. The initial contract term is two years with an optional one-year renewal. The procurement potentially carries FEMA funding and associated federal compliance obligations under the Clean Air Act and Federal Water Pollution Control Act. Geographic activity under this code is not sufficiently documented to characterize broader state or regional patterns.
Quick answers
What is UNSPSC 51391712?
UNSPSC 51391712 is Clenbuterol, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51391712?
UNSPSC 51391712 maps to 1 NIGP code, 26912 Autonomic Drugs.
On GovTribe
See everything under UNSPSC 51391712
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code